Clinical Trial Update: Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of Monoclonal Antibody F19 in advanced or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Monoclonal Antibody F19

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED